European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of, EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492–542.
Noureddin M, et al. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning. Hepatol Commun. 2022;6(7):1537–48.
Wang T, et al. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: an updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011–2018. Ann Hepatol. 2024;29(1): 101154.
Younossi ZM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335–47.
Wong VW, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842–52.
Su YH, et al. Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: a systematic review and meta-analysis. J Bone Miner Res. 2023;38(8):1092–103.
Cui A, et al. Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1215790.
Filip R, Radzki RP, Bienko M. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging. 2018;13:1879–91.
Guarino M, et al. Osteoporosis across chronic liver disease. Osteoporos Int. 2016;27(6):1967–77.
Binvignat M, et al. The role of obesity and adipose tissue dysfunction in osteoarthritis pain. Nat Rev Rheumatol. 2024;20(9):565–84.
Lu Y, et al. Association of non-alcoholic fatty liver disease with self-reported osteoarthritis among the US adults. Arthritis Res Ther. 2024;26(1):40.
Cordoba-Chacon J, et al. Growth hormone inhibits hepatic de novo lipogenesis in adult mice. Diabetes. 2015;64(9):3093–103.
Gahete MD, et al. Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. Endocrinology. 2011;152(12):4825–37.
Luque RM, et al. Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS ONE. 2011;6(1): e15767.
Cordoba-Chacon J. Loss of hepatocyte-specific PPARgamma expression ameliorates early events of steatohepatitis in mice fed the methionine and choline-deficient diet. PPAR Res. 2020;2020:9735083.
Sarmento-Cabral A, et al. GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner. J Endocrinol. 2021;248(1):31–44.
Bouxsein ML, et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25(7):1468–86.
Poudel SB, et al. Development of primary osteoarthritis during aging in genetically diverse UM-HET3 mice. Arthritis Res Ther. 2024;26(1):118.
Glasson SS, et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;18(Suppl 3):S17-23.
Kaneko H, et al. Synovial perlecan is required for osteophyte formation in knee osteoarthritis. Matrix Biol. 2013;32(3–4):178–87.
Mapp PI, et al. Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartilage. 2008;16(1):61–9.
Stilgenbauer L, et al. Microglial ER stress response via IRE1alpha regulates diet-induced metabolic imbalance and obesity in mice. Mol Metab. 2025;95: 102128.
Debarba LK, et al. Microglia mediate metabolic dysfunction from common air pollutants through NF-kappaB signaling. Diabetes. 2024;73(12):2065–77.
Schneider A, et al. Growth hormone signaling shapes the impact of environmental temperature on transcriptomic profile of different adipose tissue depots in male mice. J Gerontol A Biol Sci Med Sci. 2022;77(5):941–6.
Stilgenbauer L, et al. Growth hormone receptor (GHR) in AgRP neurons regulates thermogenesis in a sex-specific manner. Geroscience. 2023;45(3):1745–59.
Lee SM, et al. Hepatocyte-specific loss of PPARgamma protects mice from NASH and increases the therapeutic effects of rosiglitazone in the liver. Cell Mol Gastroenterol Hepatol. 2021;11(5):1291–311.
Charlton M, et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol. 2011;301(5):G825–34.
Ganz M, Csak T, Szabo G. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J Gastroenterol. 2014;20(26):8525–34.
Ishimoto T, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology. 2013;58(5):1632–43.
Santoro A, McGraw TE, Kahn BB. Insulin action in adipocytes, adipose remodeling, and systemic effects. Cell Metab. 2021;33(4):748–57.
Drescher HK, et al. The influence of different fat sources on steatohepatitis and fibrosis development in the Western diet mouse model of non-alcoholic steatohepatitis (NASH). Front Physiol. 2019;10:770.
Lee SM, et al. Hepatocyte PPARgamma contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci. 2023;80(2):39.
Barchetta I, et al. Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease. Hepatol Int. 2023;17(2):357–66.
Li M, et al. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab. 2012;97(6):2033–8.
Pan B, et al. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Osteoporos Int. 2022;33(11):2275–86.
Wester A, Hagstrom H. Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: a nationwide population-based cohort study. J Intern Med. 2022;292(3):492–500.
Kim MJ, et al. Relationship between the High Fatty Liver Index and risk of fracture. Gut Liver. 2023;17(1):119–29.
Zhao B. TNF and bone remodeling. Curr Osteoporos Rep. 2017;15(3):126–34.
de Boer TN, et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage. 2012;20(8):846–53.
Koskinen A, et al. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3. Scand J Rheumatol. 2014;43(3):249–53.
Lee JH, et al. Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro. Osteoarthritis Cartilage. 2009;17(5):613–20.
Mu Y, et al. NLRC5 attenuates inflammatory response in IL-1beta-stimulated human osteoarthritis chondrocytes through the NF-kappaB signaling pathway. Aging (Albany NY). 2021;13(16):20651–60.
Sun K, et al. IRF1 regulation of ZBP1 links mitochondrial DNA and chondrocyte damage in osteoarthritis. Cell Commun Signal. 2024;22(1):366.
Carlson EL, Karuppagounder V, Pinamont WJ, Yoshioka NK, Ahmad A, Schott EM, Le Bleu HK, Zuscik MJ, Elbarbary RA, Kamal F. Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis. Sci Transl Med. 2021;10;13(580):eaau8491. https://doi.org/10.1126/scitranslmed.aau8491.
Mlost J, Kostrzewa M, Malek N, Starowicz K. Molecular understanding of the activation of CB1 and blockade of TRPV1 receptors: implications for novel treatment strategies in osteoarthritis. Int J Mol Sci. 2018;24;19(2):342. https://doi.org/10.3390/ijms19020342.
Mahr S, et al. Cis- and trans-acting gene regulation is associated with osteoarthritis. Am J Hum Genet. 2006;78(5):793–803.
Tang C, et al. Identification of CIRBP and TRPV4 as immune-related diagnostic biomarkers in osteoarthritis. Int J Gen Med. 2021;14:10235–45.
Gavenis K, et al. Expression of ion channels of the TRP family in articular chondrocytes from osteoarthritic patients: changes between native and in vitro propagated chondrocytes. Mol Cell Biochem. 2009;321(1–2):135–43.
Liu G, et al. Inhibition of transient receptor potential canonical 6 attenuates fibroblast-like synoviocytes mediated synovial inflammation and joint destruction in rheumatoid arthritis. Clin Exp Rheumatol. 2021;39(1):115–24.
Al-Modawi RN, Brinchmann JE, Karlsen TA. Multi-pathway protective effects of microRNAs on human chondrocytes in an in vitro model of osteoarthritis. Mol Ther Nucleic Acids. 2019;17:776–90.
Okabe N, et al. Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. Mod Rheumatol. 2018;28(4):626–36.
Tew SR, et al. Post-transcriptional gene regulation following exposure of osteoarthritic human articular chondrocytes to hyperosmotic conditions. Osteoarthritis Cartilage. 2011;19(8):1036–46.
Sapede D, et al. Cartilage regeneration in zebrafish depends on Nrg1/ErbB signaling pathway. Front Cell Dev Biol. 2023;11:1123299.
Yamane S, et al. Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients. J Inflamm (Lond). 2008;5:5.
Caliogna L, et al. Pathogenesis of osteoarthritis, rheumatoid arthritis, and hemophilic arthropathy: the role of angiogenesis. Haemophilia. 2024;30(6):1256–64.
Comments (0)